Description
AxitinibisaninhibitorofVEGFRthatexhibitsanticancerchemotherapeuticandanti-angiogenicactivities.Axitinibiscurrentlyinclinicaltrialsasapotentialtreatmentforrenalcellcarcinoma.Invitro,axitinibincreaseslevelsofCD8+Tcellsanddecreaseslevelsofmyeloid-derivedsuppressorcells,inhibitingproliferationandincreasingapoptosis.Invivo,thiscompoundinhibitsexpressionofiNOS,arginase,IL-6,TNF-α,andIFN-γ,increasingapoptosisandinhibitingtumorgrowth.Inanimalmodelsoflungadenocarcinoma,axitinibdecreasestumorvasculatureandlesiongrowth.

